Related Experiment Video
Updated: May 14, 2026
09:39
Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
Rapid drug desensitization in pediatric patients: A multicenter study
Summer Tk Sze1, Daniel Leung1, Alan A Nguyen2
1Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Hong Kong, People's Republic of China.
Summary
Rapid drug desensitization is safe and effective for children with hypersensitivity to chemotherapy, monoclonal antibodies, and DMARDs. Premedication helps prevent breakthrough reactions during this essential treatment.
Area of Science:
- Pediatric Allergy and Immunology
- Clinical Pharmacology
- Rheumatology
Background:
- Drug hypersensitivity is a significant challenge in pediatric care.
- Published data on drug desensitization in children are limited.
- This study focuses on rapid desensitization for critical medications.
Purpose of the Study:
- To evaluate the safety and efficacy of rapid desensitization in pediatric patients.
- To assess the management of hypersensitivity reactions to specific drug classes.
- To identify factors influencing desensitization outcomes.
Main Methods:
- Multicenter retrospective analysis of rapid drug desensitizations (2013-2022).
- Data collected included patient demographics, drug types, hypersensitivity reactions, premedications, and breakthrough reactions.
- Statistical assessment of factors associated with hypersensitivity reactions.
Main Results:
- 26 rapid desensitizations were performed on 23 pediatric patients (median age 9.5 years).
- Underlying conditions included solid tumors, leukemia, and other medical issues.
- Most desensitizations (96%) used premedication; 23% had mild breakthrough reactions, with one anaphylaxis case. Increased premedication correlated with fewer breakthrough reactions (p=0.047).
Conclusions:
- Rapid drug desensitization is a safe and effective strategy for pediatric hypersensitivity.
- This approach enables the continued use of essential drugs like chemotherapeutics, monoclonal antibodies, and DMARDs.
- Premedication is a valuable tool in mitigating breakthrough reactions during desensitization.
Related Concept Videos
01:20Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...